HARTFORD FUNDS > HARTFORD SERIES FUND INC
HARTFORD HEALTHCARE HLS FUND
$142.09M
Avg Monthly Net Assets
$138.85M
Total Assets
$283K
Total Liabilities
$138.57M
Net Assets
HARTFORD HEALTHCARE HLS FUND is an Underlying fund in HARTFORD SERIES FUND INC
from HARTFORD FUNDS,
based in Pennsylvania,
United States of America.
The fund has two share classes
and monthly net assets of $142.09M.
On August 27th, 2024 it reported 106 holdings, the largest
being Eli Lilly & Co (12.6%), UnitedHealth Group Inc (6.8%) and Merck & Co Inc (5.6%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Class IA | C000008598 | HIAHX | |
| Class IB | C000008599 | HBGHX |
Holdings
From latest NPORT-P, filed August 27th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| Abbott Laboratories | Long | Equity-common | US | $813K | 8K | 0.59 |
| AbbVie Inc | Long | Equity-common | US | $3M | 18K | 2.26 |
| Acadia Healthcare Co Inc | Long | Equity-common | US | $2M | 27K | 1.31 |
| Addus HomeCare Corp | Long | Equity-common | US | $776K | 7K | 0.56 |
| Agilent Technologies Inc | Long | Equity-common | US | $2M | 12K | 1.16 |
| agilon health Inc | Long | Equity-common | US | $682K | 104K | 0.49 |
| Akero Therapeutics Inc | Long | Equity-common | US | $370K | 16K | 0.27 |
| Alkermes PLC | Long | Equity-common | IE | $450K | 19K | 0.32 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $1M | 5K | 0.82 |
| Amgen Inc | Long | Equity-common | US | $567K | 2K | 0.41 |
| Apellis Pharmaceuticals Inc | Long | Equity-common | US | $451K | 12K | 0.33 |
| Argenx SE | Long | Equity-common | NL | $2M | 4K | 1.09 |
| Ascendis Pharma A/S | Long | Equity-common | DK | $692K | 5K | 0.50 |
| Astellas Pharma Inc | Long | Equity-common | JP | $791K | 80K | 0.57 |
| AstraZeneca PLC | Long | Equity-common | GB | $3M | 35K | 1.99 |
| Autolus Therapeutics PLC | Long | Equity-common | GB | $221K | 64K | 0.16 |
| Avidity Biosciences Inc | Long | Equity-common | US | $570K | 14K | 0.41 |
| Bio-Techne Corp | Long | Equity-common | US | $441K | 6K | 0.32 |
| Biogen Inc | Long | Equity-common | US | $1M | 5K | 0.82 |
| Blueprint Medicines Corp | Long | Equity-common | US | $398K | 4K | 0.29 |
| Boston Scientific Corp | Long | Equity-common | US | $5M | 60K | 3.33 |
| Bridgebio Pharma Inc | Long | Equity-common | US | $247K | 10K | 0.18 |
| Celldex Therapeutics Inc | Long | Equity-common | US | $698K | 19K | 0.50 |
| Cencora Inc | Long | Equity-common | US | $3M | 12K | 1.95 |
| Centene Corp | Long | Equity-common | US | $2M | 32K | 1.54 |
| Chugai Pharmaceutical Co Ltd | Long | Equity-common | JP | $847K | 24K | 0.61 |
| CITIBANK NA DDCA | Long | Short-term investment vehicle | US | $8K | 8K | 0.01 |
| CONTRA ABIOMED INC | Derivative-equity | US | $902.7 | 885 | 0.00 | |
| Crinetics Pharmaceuticals Inc | Long | Equity-common | US | $603K | 13K | 0.43 |
| Cytokinetics Inc | Long | Equity-common | US | $479K | 9K | 0.35 |
| Daiichi Sankyo Co Ltd | Long | Equity-common | JP | $1M | 40K | 1.00 |
| Danaher Corp | Long | Equity-common | US | $5M | 20K | 3.57 |
| Dexcom Inc | Long | Equity-common | US | $2M | 18K | 1.49 |
| DiaSorin SpA | Long | Equity-common | IT | $511K | 5K | 0.37 |
| Disc Medicine Inc | Long | Equity-common | US | $455K | 10K | 0.33 |
| Edwards Lifesciences Corp | Long | Equity-common | US | $3M | 31K | 2.07 |
| Eisai Co Ltd | Long | Equity-common | JP | $857K | 21K | 0.62 |
| Elanco Animal Health Inc | Long | Equity-common | US | $642K | 45K | 0.46 |
| Eli Lilly & Co | Long | Equity-common | US | $17M | 19K | 12.57 |
| Encompass Health Corp | Long | Equity-common | US | $958K | 11K | 0.69 |
| Evolent Health Inc | Long | Equity-common | US | $677K | 35K | 0.49 |
| Exact Sciences Corp | Long | Equity-common | US | $495K | 12K | 0.36 |
| FIXED INC CLEARING CORP.REPO (Fixed Income Clearing Corp.) | Long | Repurchase agreement | US | $429K | – | 0.31 |
| Galderma Group AG | Long | Equity-common | CH | $2M | 18K | 1.08 |
| Genmab A/S | Long | Equity-common | DK | $329K | 1K | 0.24 |
| Genus PLC | Long | Equity-common | GB | $259K | 12K | 0.19 |
| Goldman Sachs Financial Square Funds - Government Fund | Long | Short-term investment vehicle | US | $24K | 24K | 0.02 |
| GSK PLC | Long | Equity-common | GB | $1M | 53K | 0.74 |
| HCA Healthcare Inc | Long | Equity-common | US | $3M | 10K | 2.40 |
| Hologic Inc | Long | Equity-common | US | $1M | 14K | 0.74 |
| HSBC U.S. Government Money Market Fund | Long | Short-term investment vehicle | US | $79K | 79K | 0.06 |
| Humana Inc | Long | Equity-common | US | $2M | 6K | 1.59 |
| ICON PLC | Long | Equity-common | IE | $2M | 5K | 1.21 |
| Immatics NV | Long | Equity-common | NL | $466K | 40K | 0.34 |
| Immunocore Holdings PLC | Long | Equity-common | GB | $420K | 12K | 0.30 |
| Inspire Medical Systems Inc | Long | Equity-common | US | $308K | 2K | 0.22 |
| Insulet Corp | Long | Equity-common | US | $979K | 5K | 0.71 |
| Intuitive Surgical Inc | Long | Equity-common | US | $2M | 4K | 1.33 |
| Invesco Government & Agency Portfolio | Long | Short-term investment vehicle | US | $24K | 24K | 0.02 |
| Labcorp Holdings Inc | Long | Equity-common | US | $1M | 6K | 0.82 |
| Legend Biotech Corp | Long | Equity-common | KY | $269K | 6K | 0.19 |
| LifeStance Health Group Inc | Long | Equity-common | US | $563K | 115K | 0.41 |
| Longboard Pharmaceuticals Inc | Long | Equity-common | US | $495K | 18K | 0.36 |
| Merck & Co Inc | Long | Equity-common | US | $8M | 63K | 5.62 |
| Merus NV | Long | Equity-common | NL | $547K | 9K | 0.40 |
| Moderna Inc | Long | Equity-common | US | $444K | 4K | 0.32 |
| Molina Healthcare Inc | Long | Equity-common | US | $2M | 6K | 1.29 |
| MoonLake Immunotherapeutics | Long | Equity-common | KY | $277K | 6K | 0.20 |
| Morgan Stanley Institutional Liquidity Funds - Government Portfolio (Morgan Stanley & Co. LLC) | Long | Short-term investment vehicle | US | $24K | 24K | 0.02 |
| Morphic Holding Inc | Long | Equity-common | US | $245K | 7K | 0.18 |
| Natera Inc | Long | Equity-common | US | $280K | 3K | 0.20 |
| Novartis AG | Long | Equity-common | CH | $638K | 6K | 0.46 |
| Novo Nordisk A/S | Long | Equity-common | DK | $793K | 6K | 0.57 |
| Nuvalent Inc | Long | Equity-common | US | $332K | 4K | 0.24 |
| Option Care Health Inc | Long | Equity-common | US | $787K | 28K | 0.57 |
| Otsuka Holdings Co Ltd | Long | Equity-common | JP | $875K | 21K | 0.63 |
| PACS Group Inc | Long | Equity-common | US | $404K | 14K | 0.29 |
| Pfizer Inc | Long | Equity-common | US | $699K | 25K | 0.50 |
| Privia Health Group Inc | Long | Equity-common | US | $456K | 26K | 0.33 |
| PTC Therapeutics Inc | Long | Equity-common | US | $309K | 10K | 0.22 |
| QIAGEN NV | Long | Equity-common | NL | $658K | 16K | 0.48 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $3M | 2K | 1.82 |
| Repligen Corp | Long | Equity-common | US | $562K | 4K | 0.41 |
| REVOLUTION Medicines Inc | Long | Equity-common | US | $764K | 20K | 0.55 |
| Rocket Pharmaceuticals Inc | Long | Equity-common | US | $441K | 20K | 0.32 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $755K | 5K | 0.54 |
| Savara Inc | Long | Equity-common | US | $219K | 54K | 0.16 |
| Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | Long | Equity-common | CN | $345K | 16K | 0.25 |
| Soleno Therapeutics Inc | Long | Equity-common | US | $377K | 9K | 0.27 |
| Structure Therapeutics Inc | Long | Equity-common | KY | $563K | 14K | 0.41 |
| Stryker Corp | Long | Equity-common | US | $3M | 10K | 2.43 |
| Surgery Partners Inc | Long | Equity-common | US | $529K | 22K | 0.38 |
| Syndax Pharmaceuticals Inc | Long | Equity-common | US | $389K | 19K | 0.28 |
| Tecan Group AG | Long | Equity-common | CH | $412K | 1K | 0.30 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $4M | 7K | 2.83 |
| UCB SA | Long | Equity-common | BE | $880K | 6K | 0.64 |
| Ultragenyx Pharmaceutical Inc | Long | Equity-common | US | $445K | 11K | 0.32 |
| United Therapeutics Corp | Long | Equity-common | US | $1M | 3K | 0.74 |
| UnitedHealth Group Inc | Long | Equity-common | US | $9M | 19K | 6.82 |
| Vaxcyte Inc | Long | Equity-common | US | $630K | 8K | 0.45 |
| Veracyte Inc | Long | Equity-common | US | $385K | 18K | 0.28 |
| Verona Pharma PLC | Long | Equity-common | GB | $402K | 28K | 0.29 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $4M | 8K | 2.58 |
| Xenon Pharmaceuticals Inc | Long | Equity-common | CA | $448K | 11K | 0.32 |
| Zai Lab Ltd | Long | Equity-common | KY | $224K | 13K | 0.16 |
| Zoetis Inc | Long | Equity-common | US | $3M | 15K | 1.93 |
Address
HARTFORD SERIES FUND INC
690 LEE ROAD
WAYNE
Pennsylvania
19087
United States of America
Websites
Directors
Paul L. Rosenberg
James E. Davey
Andrew A. Johnson
Robin C. Beery
Derrick D. Cephas
Hilary E. Ackermann
Christine R. Detrick
David Sung
John J. Gauthier
Transfer Agents
Hartford Administrative Services Company
Pricing Services
S&P Global Inc.
PricingDirect Inc.
ICE Data Services, Inc.
London Stock Exchange Group PLC
Bloomberg L.P.
Custodians
Citibank, Anonim Sirketi
State Street Bank and Trust Company
State Street Bank and Trust Company (Edinburgh, GB, Branch)
Standard Chartered Bank Ghana PLC
Royal Bank of Canada
Banco Nacional de Mexico, S.A., Integrante del Grupo Financiero Banamex
UBS Switzerland AG
Standard Chartered Bank Malaysia Berhad
Ceskoslovenska obchodni banka, a. s.
Bank Hapoalim B.M.
Standard Chartered Bank (Thai) Public Company Limited
Citibank Europe Public Limited Company
Skandinaviska Enskilda Banken AB (Helsinki, Uusimaa, FI, Branch)
State Street Bank International GmbH
Standard Chartered Bank (Jakarta, Jakarta, ID, Branch)
Citibank, National Association (Singapore, SG, Branch)
Banco de Chile
Intesa Sanpaolo S.p.A.
Bank Handlowy w Warszawie Spolka Akcyjna
Euroclear Bank
UniCredit Bank Austria AG
HSBC Bank Bermuda Limited
Skandinaviska Enskilda Banken AB (Oslo, Oslo, NO, Branch)
Cititrust Colombia S A Sociedad Fiduciaria
UniCredit Bank Czech Republic and Slovakia, a.s. (Bratislava, Bratislavsky, SK, Branch)
Citibank, National Association (Sao Paulo, Sao Paulo, BR, Branch)
FirstRand Bank Limited
Stanbic IBTC Bank PLC
Citibank Europe Public Limited Company (Budapest, HU, Branch)
State Street Trust Company Canada
BNP Paribas
The Hongkong and Shanghai Banking Corporation Limited (Chuo ku, Tokyo, JP, Branch)
Deutsche Bank Aktiengesellschaft (Mumbai, Maharashtra, IN, Branch)
Citibank del Peru S.A.
The Hongkong and Shanghai Banking Corporation Limited
Standard Chartered Bank (Makati City, Metro Manila, PH, Branch)
Skandinaviska Enskilda Banken A/S
Citibank Europe Public Limited Company (Bucharest, Bucharest, RO, Branch)
The Hongkong and Shanghai Banking Corporation Limited (Auckland, Auckland, NZ, Branch)
The Hongkong and Shanghai Banking Corporation Limited (Sydney, NSW, AU, Branch)
Shareholder Servicing Agents
Hartford Administrative Services Company
Admins
Hartford Funds Management Company, LLC
Brokers
Goldman Sachs & Co. LLC